Phosphatidylserine (PS) belongs to a special category of fat-soluble substances called phospholipids, which are essential components of cell membranes. PS is found in high concentrations in the brain.
Where is it found?
PS is found in only trace amounts in a typical diet. Very small amounts are present in lecithin. The body manufactures PS from phospholipid building blocks. PS research has used material derived from a bovine source. Currently, PS that is commercially available is derived from soy.
Phosphatidylserine has been used in connection with the following conditions (refer to the individual health concern for complete information):
| Science Rating | Health Concerns |
|---|---|
 | Age-related cognitive decline (ARCD) |
 | Athletic performance (to enhance enurance in young active men) |
 | Alzheimer’s disease Depression Parkinson’s disease |
| Reliable and relatively consistent scientific data showing a substantial health benefit. Contradictory, insufficient, or preliminary studies suggesting a health benefit or minimal health benefit. For an herb, supported by traditional use but minimal or no scientific evidence. For a supplement, little scientific support and/or minimal health benefit. | |
Who is likely to be deficient?
PS is not an essential nutrient, and therefore dietary deficiencies do not occur. Adults age 50 and older, especially those with age-related cognitive decline, may not synthesize enough PS, and appear most likely to benefit from supplemental PS.
How much is usually taken?
Positive effects on mental function have been achieved using 200–500 mg per day of bovine PS; most studies used 300 mg per day. Preliminary animal research shows that the soy-derived PS does have effects on brain function similar to effects from the bovine source. 1 2 3
Are there any side effects or interactions?
No significant side effects associated with PS have been reported.
References
1. Furushiro M, Suzuki S, Shishido Y, et al. Effects of oral administration of soybean lecithin transphosphatidylated phosphatidylserine on impaired learning of passive avoidance in mice. Jpn J Pharmacol 1997;75:447–50.
2. Sakai M, Yamatoya H, Kudo S. Pharmacological effects of phosphatidylserine enzymatically synthesized from soybean lecithin on brain functions in rodents. J Nutr Sci Vitaminol (Tokyo) 1996;42:47–54.
3. Blokland A, Honig W, Brouns F, et al. Cognition-enhancing properties of subchronic phosphatidylserine (PS) treatment in middle-aged rats: comparison of bovine cortex PS with egg PS and soybean PS. Nutrition 1999;15:778–83.
Copyright 2007, Healthnotes, Inc., 1505 S.E. Gideon St., Suite 200, Portland, Oregon 97202, www.Healthnotes.com.
2006-09-07
